A STUDY TO ASSESS THE EFFICACY AND SAFETY OF DUPILUMAB IN PATIENTS WITH SEVERE ATOPIC DERMATITIS (AD) THAT ARE NOT CONTROLLED WITH ORAL CYCLOSPORINE A (CSA) OR FOR THOSE WHO CANNOT TAKE ORAL CSA BECAUSE IT IS NOT MEDICALLY ADVISABLE: